LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics

LeMaitre Vascular, Inc. (LMAT): $46.03

0.15 (+0.33%)

POWR Rating

Component Grades














  • LMAT scores best on the Quality dimension, with a Quality rank ahead of 91.21% of US stocks.
  • LMAT's strongest trending metric is Value; it's been moving up over the last 177 days.
  • LMAT's current lowest rank is in the Momentum metric (where it is better than 12.43% of US stocks).

LMAT Stock Summary

  • LMAT's current price/earnings ratio is 47.72, which is higher than 87.11% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for LMAT is currently 38.36, higher than 87.21% of US stocks with positive operating cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for LEMAITRE VASCULAR INC; that's greater than it is for merely 11.33% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to LEMAITRE VASCULAR INC are GMED, CSPI, SHYF, MMSI, and INTT.
  • LMAT's SEC filings can be seen here. And to visit LEMAITRE VASCULAR INC's official web site, go to www.lemaitre.com.

LMAT Valuation Summary

  • LMAT's EV/EBIT ratio is 36.9; this is 272.73% higher than that of the median Healthcare stock.
  • Over the past 198 months, LMAT's price/earnings ratio has gone up 263.

Below are key valuation metrics over time for LMAT.

Stock Date P/S P/B P/E EV/EBIT
LMAT 2023-01-20 6.5 4.0 49.0 36.9
LMAT 2023-01-19 6.4 3.9 48.4 36.4
LMAT 2023-01-18 6.1 3.8 46.5 35.0
LMAT 2023-01-17 6.2 3.8 47.0 35.4
LMAT 2023-01-13 6.3 3.9 47.9 36.1
LMAT 2023-01-12 6.3 3.9 47.8 36.0

LMAT Growth Metrics

    The 2 year revenue growth rate now stands at 32.52%.
  • Its 2 year price growth rate is now at 53.03%.
  • Its 3 year net income to common stockholders growth rate is now at 19.52%.
Over the past 33 months, LMAT's revenue has gone up $42,968,000.

The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 160.2 26.357 21.184
2022-06-30 159.54 33.09 22.232
2022-03-31 158.102 33.739 27.016
2021-12-31 154.424 35.102 26.907
2021-09-30 152.469 44.198 27.765
2021-06-30 150.517 44.235 28.774

LMAT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
  • LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
  • ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.

The table below shows LMAT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.589 0.655 0.287
2021-06-30 0.597 0.649 0.299
2021-03-31 0.530 0.653 0.241
2020-12-31 0.542 0.654 0.220
2020-09-30 0.548 0.657 0.196
2020-06-30 0.574 0.677 0.177

LMAT Price Target

For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $66.14 Average Broker Recommendation 1.5 (Moderate Buy)

LMAT Stock Price Chart Interactive Chart >

Price chart for LMAT

LMAT Price/Volume Stats

Current price $46.03 52-week high $56.38
Prev. close $45.88 52-week low $38.32
Day low $45.37 Volume 49,700
Day high $46.86 Avg. volume 66,463
50-day MA $45.98 Dividend yield 1.09%
200-day MA $47.09 Market Cap 1.01B

LeMaitre Vascular, Inc. (LMAT) Company Bio

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.

LMAT Latest News Stream

Event/Time News Detail
Loading, please wait...

LMAT Latest Social Stream

Loading social stream, please wait...

View Full LMAT Social Stream

Latest LMAT News From Around the Web

Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.

VREX vs. LMAT: Which Stock Is the Better Value Option?

VREX vs. LMAT: Which Stock Is the Better Value Option?

Yahoo | January 24, 2023

Is This Small-Cap Dividend Stock a Buy?

LeMaitre Vascular isn't well-known to investors. But vascular surgeons do know the company well.

Yahoo | January 13, 2023

ESLOY vs. LMAT: Which Stock Should Value Investors Buy Now?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

Yahoo | January 6, 2023

ESLOY or LMAT: Which Is the Better Value Stock Right Now?

ESLOY vs. LMAT: Which Stock Is the Better Value Option?

Yahoo | December 21, 2022

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

LeMaitre Vascular (NASDAQ:LMAT) has had a rough three months with its share price down 8.3%. However, the company's...

Yahoo | December 18, 2022

Read More 'LMAT' Stories Here

LMAT Price Returns

1-mo 0.02%
3-mo 5.06%
6-mo -14.14%
1-year 9.95%
3-year 32.07%
5-year 37.15%
YTD 0.02%
2022 -7.40%
2021 25.10%
2020 14.09%
2019 53.77%
2018 -25.13%

LMAT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LMAT Dividend History

Continue Researching LMAT

Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:

Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8296 seconds.